Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Nephrology

The Long View: Monitoring, Family, and Wellness

At a Glance

Long-term ADPKD management involves regular monitoring of blood pressure, kidney function, and kidney volume. Key aspects of care also include targeted screening for brain aneurysms, genetic counseling for family planning, and proactively managing the emotional impact of chronic testing.

Living with ADPKD is a marathon, not a sprint. Because the condition is progressive and inherited, long-term management involves a combination of regular medical surveillance, proactive family planning, and looking after your emotional well-being [1][2].

Your Long-Term Monitoring Schedule

The goal of monitoring is to catch changes early so you and your doctor can adjust your treatment plan. While your specific schedule will depend on your Mayo Imaging Classification (risk level), a typical surveillance plan includes:

  • Blood Pressure: Checked at every office visit and ideally monitored at home. For many younger patients, the goal is a “rigorous” target of 110/75 mmHg or lower [3][4].
  • Kidney Function (eGFR): Blood tests are typically performed every 3 to 12 months to monitor how well your kidneys are filtering waste [5][4].
  • Imaging (MRI or Ultrasound): Repeat imaging to track Total Kidney Volume (TKV) may be done every 1 to 3 years, depending on how quickly your disease is progressing and whether you are on medications like tolvaptan [6][7].

Screening for Brain Aneurysms

An intracranial aneurysm (a bulge in a blood vessel in the brain) occurs in about 9% of people with ADPKD [8]. While this sounds concerning, most aneurysms do not rupture. Screening with a specialized MRI called an MRA is recommended if you have [8][9]:

  1. A family history of brain aneurysms or a “brain bleed” (hemorrhagic stroke).
  2. A high-risk profile, such as uncontrolled high blood pressure or a history of smoking [8].
  3. A high-risk occupation where a sudden medical emergency would endanger others (such as an airline pilot or bus driver), or if you have an upcoming major surgery [10].

Family Planning and Genetic Counseling

ADPKD is autosomal dominant, meaning if one parent has the gene, there is a 50% chance of passing it to each child [2][11]. This reality can carry a significant emotional burden, and genetic counseling is a vital resource for navigating these decisions [12].

For those who wish to ensure they do not pass the gene to their children, options include Pre-implantation Genetic Testing (PGT-M) [13]. This involves using IVF (in vitro fertilization) to test embryos for the PKD1 or PKD2 mutation before they are implanted [14][15]. This process requires first identifying your family’s specific genetic mutation through a blood test [16].

Pregnancy Considerations: Women with ADPKD who already have hypertension or declining kidney function face a higher risk of pregnancy complications, such as preeclampsia. These pregnancies should be closely monitored by a high-risk OB-GYN in conjunction with a nephrologist [17].

Managing “Scanxiety” and Emotional Health

Chronic monitoring can take a toll. It is common for patients to experience “scanxiety”—the feelings of dread or anxiety that arise before an upcoming MRI or lab test [1][18].

Acknowledging that your mental health is just as important as your kidney function is key. Many patients find it helpful to [1]:

  • Connect with a community: Support groups (online or in-person) can provide a space to talk with others who understand the unique stress of ADPKD.
  • Focus on the “Now”: While the scores and classes predict the future, your daily management—like staying hydrated and managing salt—is what you can control today.
  • Involve a specialist: A therapist who specializes in chronic or genetic illness can help you process the weight of the diagnosis and the ongoing surveillance [12].

By staying informed and proactive, you can navigate the long-term path of ADPKD with greater confidence and a sense of empowerment over your health [19].

Common questions in this guide

How often should I have an MRI to check my kidney volume?
Your monitoring schedule depends on your specific risk level, known as your Mayo Imaging Classification. Typically, doctors recommend repeat imaging with an MRI or ultrasound to track your total kidney volume every 1 to 3 years.
Do I need to be screened for brain aneurysms if I have ADPKD?
Screening is typically recommended if you have a family history of brain aneurysms, uncontrolled high blood pressure, or a high-risk occupation. While about 9 percent of people with ADPKD develop an aneurysm, most do not rupture.
What are the chances of passing ADPKD to my children?
Because ADPKD is an autosomal dominant genetic condition, there is a 50 percent chance of passing the mutated gene to each child. A genetic counselor can help you understand these risks and explore your reproductive options.
What is PGT-M and how can it help with family planning?
Pre-implantation Genetic Testing (PGT-M) is an option for people who want to ensure they do not pass the ADPKD gene to their children. It involves using in vitro fertilization (IVF) to test embryos for the specific genetic mutation before they are implanted.
How can I deal with anxiety before my ADPKD monitoring appointments?
It is very common to experience dread or anxiety before medical tests, often called scanxiety. To cope, try connecting with support groups, focusing on daily habits you can control, and working with a therapist who specializes in chronic illness.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my Mayo Class, how often should I have an MRI to track my Total Kidney Volume (TKV)?
  2. 2.Since ADPKD is a family condition, should my siblings or children be screened, and at what age?
  3. 3.Given my personal and family history, do I meet the criteria for intracranial aneurysm screening?
  4. 4.Can you refer me to a genetic counselor to discuss family planning options like PGT-M?
  5. 5.If I feel significant anxiety before my monitoring appointments, are there resources or support groups you recommend?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    [Quality of life in patients with autosomal dominant polycystic kidney disease].

    Lecardeur L, Joly D

    Nephrologie & therapeutique 2017; (13(7)):505-510 doi:10.1016/j.nephro.2016.12.005.

    PMID: 28606406
  2. 2

    Copy Number Variation: A New Genetic Form of Polycystic Kidney and Liver Disease.

    Fujimaru T, Sohara E

    Kidney international reports 2020; (5(5)):575-576 doi:10.1016/j.ekir.2020.03.007.

    PMID: 32406422
  3. 3

    Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?

    Brosnahan GM, Abebe KZ, Moore CG, et al.

    Current hypertension reviews 2018; (14(1)):39-47 doi:10.2174/1573402114666180322110209.

    PMID: 29564978
  4. 4

    Treatment of Autosomal-Dominant Polycystic Kidney Disease.

    Jdiaa SS, Mustafa RA, Yu ASL

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2025; (85(4)):491-500 doi:10.1053/j.ajkd.2024.08.008.

    PMID: 39424253
  5. 5

    The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China.

    Xue C, Zhou CC, Wu M, Mei CL

    Kidney diseases (Basel, Switzerland) 2016; (2(3)):111-119 doi:10.1159/000449030.

    PMID: 27921038
  6. 6

    Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.

    Chebib FT, Torres VE

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2021; (78(2)):282-292 doi:10.1053/j.ajkd.2020.12.020.

    PMID: 33705818
  7. 7

    Assessing the Risk of Progression to Kidney Failure in Patients With Autosomal Dominant Polycystic Kidney Disease.

    Lanktree MB, Kline T, Pei Y

    Advances in kidney disease and health 2023; (30(5)):407-416 doi:10.1053/j.akdh.2023.06.002.

    PMID: 38097331
  8. 8

    Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.

    Sanchis IM, Shukoor S, Irazabal MV, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2019; (14(8)):1151-1160 doi:10.2215/CJN.14691218.

    PMID: 31362991
  9. 9

    Is Regular Screening for Intracranial Aneurysm Necessary in Patients with Autosomal Dominant Polycystic Kidney Disease? A Systematic Review and Meta-analysis.

    Zhou Z, Xu Y, Delcourt C, et al.

    Cerebrovascular diseases (Basel, Switzerland) 2017; (44(1-2)):75-82 doi:10.1159/000476073.

    PMID: 28502970
  10. 10

    MR Angiography Screening and Surveillance for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Cost-effectiveness Analysis.

    Malhotra A, Wu X, Matouk CC, et al.

    Radiology 2019; (291(2)):400-408 doi:10.1148/radiol.2019181399.

    PMID: 30777807
  11. 11

    Identifying gene mutations of Chinese patients with polycystic kidney disease through targeted next-generation sequencing technology.

    Wang T, Li Q, Shang S, et al.

    Molecular genetics & genomic medicine 2019; (7(6)):e720 doi:10.1002/mgg3.720.

    PMID: 31056860
  12. 12

    International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people.

    Gimpel C, Bergmann C, Bockenhauer D, et al.

    Nature reviews. Nephrology 2019; (15(11)):713-726 doi:10.1038/s41581-019-0155-2.

    PMID: 31118499
  13. 13

    System analysis of gene mutations and clinical phenotype in Chinese patients with autosomal-dominant polycystic kidney disease.

    Jin M, Xie Y, Chen Z, et al.

    Scientific reports 2016; (6()):35945 doi:10.1038/srep35945.

    PMID: 27782177
  14. 14

    Biallelic inheritance of hypomorphic PKD1 variants is highly prevalent in very early onset polycystic kidney disease.

    Durkie M, Chong J, Valluru MK, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(4)):689-697 doi:10.1038/s41436-020-01026-4.

    PMID: 33168999
  15. 15

    Comprehensive Analysis of PKD1 and PKD2 by Long-Read Sequencing in Autosomal Dominant Polycystic Kidney Disease.

    Xu D, Mao A, Chen L, et al.

    Clinical chemistry 2024; (70(6)):841-854 doi:10.1093/clinchem/hvae030.

    PMID: 38527221
  16. 16

    Many lessons still to learn about autosomal dominant polycystic kidney disease.

    Orr S, Sayer JA

    Journal of rare diseases (Berlin, Germany) 2023; (2(1)):13 doi:10.1007/s44162-023-00017-8.

    PMID: 37664187
  17. 17

    RETRACTED: Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

    Kebede MA, Mengistu YT, Loge BY, et al.

    Journal of personalized medicine 2024; (14(9)) doi:10.3390/jpm14090936.

    PMID: 39338190
  18. 18

    Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease.

    Oberdhan D, Yarlas A, Bjorner JB, Krasa H

    Kidney medicine 2024; (6(1)):100755 doi:10.1016/j.xkme.2023.100755.

    PMID: 38192435
  19. 19

    Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies.

    Lanktree MB, Haghighi A, di Bari I, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2021; (16(5)):790-799 doi:10.2215/CJN.02320220.

    PMID: 32690722

This page is for informational purposes only and does not replace professional medical advice. Always consult your nephrologist or genetic counselor about your specific ADPKD management plan.

Get notified when new evidence is published on Autosomal dominant polycystic kidney disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.